Uruguay's Cannabis Pharmacies Are Booming. Its Banks Still Won't Touch the Money

September 17, 2026

Photo by cottonbro studio via Pexels.

Walk into one of the sixty pharmacies in Uruguay now licensed to sell cannabis to registered adults, and the transaction looks almost boring by design: a government ID scan, a fingerprint check against the national registry, a fixed weekly cap, and a small paper bag handed across the counter next to the cough syrup and blood pressure medication. It is, by any legal measure, as ordinary a retail sale as buying aspirin. Yet in a back office somewhere, that same pharmacy is probably counting the day's cannabis receipts in cash, because no correspondent bank in New York or Frankfurt wants that money touching an account they can see.

That's the contradiction sitting at the center of Uruguay's cannabis system nine years after the first legal gram was sold: a product fully authorized by the state, tracked by a government agency down to the kilogram, and still functionally unbankable the moment it crosses into the international financial system. The plant is legal. The money it generates behaves like it isn't.

Three Ways to Buy Legally, Nine Years In

Uruguay didn't back into cannabis legalization gradually the way some jurisdictions did -- it wrote the whole architecture into a single statute. President Jose Mujica signed Law 19.172 in December 2013, and the government spent the better part of two years building out the regulatory body before anything actually reached consumers. That agency, the Instituto de Regulacion y Control del Cannabis (IRCCA), still runs the entire show: licensing growers, auditing clubs, setting purchase limits, and keeping the national registry that every legal buyer has to join.

The law set up three distinct doors into the legal market, and they've aged very differently. You can register to buy at a pharmacy counter. You can register as a home grower, capped at six plants per household. Or you can join a membership club -- outfits of 15 to 45 members that are permitted to cultivate up to 99 plants collectively and distribute the harvest among registered members. As of April 30, 2026, IRCCA counted 120,083 total registered users across the system: 88,955 in the pharmacy channel, about 74 percent of everyone registered; 20,798 club members; and 10,330 home growers. There are now 585 licensed clubs operating in all nineteen of Uruguay's departments, evidence that the club model has put down roots well beyond Montevideo.

What's notable is the direction each channel is moving. Home cultivation, which many assumed would be the backbone of a country with a strong tradition of small-scale self-sufficiency, has actually shrunk -- from a peak near 14,000 registered growers in 2022 down to 10,330 today. Pharmacy registration, meanwhile, keeps climbing every year without exception. Nine years in, Uruguayans are voting with their feet for convenience over cultivation, even in a system explicitly designed to let them grow their own.

Why It Took Until 2017 to Sell a Single Gram

The law existed for nearly four years before it did anything. Mujica signed Law 19.172 in December 2013, but the first legal gram wasn't sold over a pharmacy counter until July 19, 2017. That gap wasn't bureaucratic foot-dragging over licensing paperwork -- it was banking, plain and simple, and it set the tone for everything that's followed.

The state bank, Banco Republica (BROU), initially agreed to hold accounts for the roughly fifteen pharmacies, licensed producers, and clubs that made up the early legal market. That arrangement lasted about as long as it took international correspondent banks to notice. Bank of America and Citibank, both of which process US dollar transactions on BROU's behalf, warned they would sever correspondent ties with the Uruguayan bank entirely if it kept servicing cannabis-linked accounts. For a small economy like Uruguay's, losing dollar-clearing access through a major US correspondent isn't a manageable inconvenience -- it's an existential threat to how the whole banking system interacts with the world.

The fallout landed on individual businesses fast. A pharmacy in Montevideo dropped out of the cannabis program entirely after Banco Santander threatened to close its commercial account over the association. Itau, the Brazilian bank with a major Uruguayan presence, went further and canceled accounts held by licensed producers and several clubs, cutting them loose from ordinary banking services altogether. With no bank willing to touch the money, pharmacies had to run their cannabis sales as cash-only from day one -- not as a preference, but because banks made clear that any electronic handling of the funds put the pharmacy's entire relationship with that bank at risk. Nearly a decade later, that cash-only reality hasn't meaningfully changed.

The Root of the Problem: FATF Rules and a Financial-Inclusion Law That Contradict Each Other

Photo by Jakub Żerdzicki via Unsplash.

The banking standoff isn't really a Uruguayan policy failure -- it's what happens when two legitimate regulatory frameworks point in opposite directions. Uruguay's financial regulator requires banks to verify a client's identity and the nature of their business activity before opening or maintaining an account, standard know-your-customer practice anywhere. On paper, a licensed pharmacy or IRCCA-registered producer should sail through that check, since their cannabis business is entirely legal and heavily documented by the state.

The complication comes from outside Uruguay's borders. As a member of the Financial Action Task Force (FATF, or GAFI in Spanish), Uruguay has committed to international anti-money-laundering standards, and the correspondent banks that connect BROU and other Uruguayan institutions to the US dollar and euro clearing systems apply their own risk models on top of that. Because cannabis remains federally illegal in the United States and is treated inconsistently across the EU, those correspondent banks classify cannabis revenue as high-risk for money laundering regardless of what Uruguayan law says about it. Domestic legality simply doesn't factor into a New York correspondent bank's calculation of what happens to its own US regulatory standing.

Making matters worse, a separate Uruguayan financial-inclusion law requires businesses to be banked in order to operate legally and pay employee salaries -- closing off the obvious workaround of just running everything in cash indefinitely. So pharmacies and clubs are stuck between one law that says you must have a bank account and an international banking system that says it won't give you one, at least not one connected to anything beyond Uruguay's own borders. Commentary out of Montevideo as recently as 2026 still describes this as an unresolved knot rather than a problem anyone has found a fix for, and there's no indication that's about to change on its own.

A Record Year for Sales Anyway

Uruguay's legal cannabis production for pharmacies rose sharply from 3,500 kg in 2024 to 4,658 kg in 2025, marking a roughly 33% year-over-year increase.

None of that banking friction has stopped Uruguayans from buying cannabis in record quantities. IRCCA data show the country sold more than 9 tons of legal adult-use cannabis in 2025, the highest volume since sales began in 2017. Registered consumers bought 4,290 kilograms through pharmacies that year alone, more than a ton above 2024's total, while state-licensed producers grew a record 4,658 kilograms specifically for pharmacy distribution.

The pace has only picked up heading into 2026. March alone saw 525 kilograms sold nationwide, a 51 percent jump over March 2025 -- not a modest uptick but a genuine acceleration in a market that's already nine years old. Some of that growth traces directly back to product: the introduction of the Epsilon strain, sitting at roughly 20 percent THC, gave pharmacy buyers access to potency levels well above the low-THC offerings that defined the market's early years and had frustrated consumers who found their way back to the illicit market or simply grew their own instead.

Access has expanded right alongside demand. Sixty pharmacies now sell adult-use cannabis across Uruguay, twenty of them added just between January 2025 and April 2026 -- a genuinely fast buildout for a retail network that took years to get off the ground in the first place. Montevideo, unsurprisingly, leads with 26 pharmacies, followed by Canelones with 8 and Maldonado with 7. For a country of roughly 3.4 million people, that's a meaningfully dense retail footprint, and it's arriving at exactly the moment the banking problem should, by rights, be dragging the whole system down.

What Stalled Because the Banks Never Came Around

Photo by Nezaket via Pexels.

The banking freeze hasn't just been an accounting headache -- it's actively capped what the industry can become. Export ambitions for Uruguay's adult-use producers have gone essentially nowhere, not because of a lack of product or expertise, but because international banking access never normalized enough to support cross-border trade in the way it has for, say, Canadian medical cannabis exporters working with correspondent banks willing to touch the sector. Without reliable financial channels connecting Uruguayan producers to buyers abroad, export talk has stayed mostly theoretical.

On the ground, the producers and clubs that got cut off by banks like Itau have had to improvise around basic functions that most businesses take for granted -- paying suppliers, running payroll, keeping records that satisfy both IRCCA and tax authorities without a normal transaction trail to point to. It's the kind of friction that eats management time and keeps operations smaller and more fragile than they'd otherwise need to be.

What makes Uruguay's situation stand out, even among the fairly short list of countries with any form of legal cannabis retail, is the sheer mismatch: a mature, tightly regulated retail market moving 9-plus tons a year sitting on top of a banking sector that still treats the whole thing as radioactive. The government's National Drug Strategy for 2026-2030 does flag regulatory review as a priority, with language about improving accessibility, quality, and efficiency and removing market barriers. But so far the concrete proposals under that banner have centered mostly on opening pharmacy access to tourists, not on any direct plan to get producers and pharmacies back into normal banking relationships. The barrier regulators seem most focused on right now isn't the financial one.

A Model Other Countries Watch, Warts and All

Photo by TheoRivierenlaan via Pixabay.

Uruguay is still, nine years on, the only country running cannabis retail as a state-controlled pharmacy system -- a genuinely different model from Canada's network of licensed private retailers or the patchwork of state-by-state dispensary systems in the US. And on its own terms, the experiment has worked: the government has shown a state can operate legal cannabis retail at real scale, moving more than 9 tons a year through pharmacy counters, without registered users drifting back to the black market in any visible way.

What the banking standoff proves is a separate and less comfortable lesson: domestic legality doesn't insulate a country from how the international financial system treats cannabis. Uruguay wrote clean, comprehensive legislation, built a functioning regulator, and still can't get its pharmacies a normal bank account, because the decision isn't really being made in Montevideo. It's being made by correspondent banks in New York and European clearing houses weighing FATF guidance and US federal law against the risk of losing their own banking licenses. Real movement on this almost certainly requires a shift at that level -- in FATF's guidance, or in how US and EU correspondent banks assess cannabis risk -- rather than anything further Uruguay itself can legislate.

For the people actually running clubs and pharmacies, none of that policy analysis changes the daily reality. Nine years after Mujica's signature, the practical experience of participating in Uruguay's legal cannabis market still runs through cash registers, hand-kept ledgers, and whatever informal bookkeeping arrangement keeps a business one step ahead of losing its next bank relationship.

Look at where the National Drug Strategy 2026-2030 actually puts its energy and the priorities become clear. Regulators are drafting plans to let tourists buy at pharmacy counters -- a move that would meaningfully grow the customer base and generate fresh headlines about Uruguay's cannabis openness -- while the banking standoff that's shaped the market since 2017 goes largely unaddressed in the same document. That's not necessarily a mistake so much as a reflection of where Uruguay actually has leverage. Expanding who can walk into a pharmacy is a domestic policy choice. Getting BROU back into good standing with Bank of America and Citibank over cannabis accounts is not, and no amount of clean IRCCA paperwork changes that math.

So expect the pattern to continue: rising sales volumes, more pharmacies, stronger strains, maybe tourists at the counter within a few years -- layered on top of a banking arrangement that still looks, structurally, like 2017. Uruguay solved the legal question a long time ago. The financial one belongs to Washington and Basel as much as it belongs to Montevideo, and nothing in the current strategy suggests anyone expects that to change soon.